104 results
Page 4 of 6
8-K
b1i5h
9 Dec 20
Entry into a Material Definitive Agreement
4:38pm
8-K
EX-1.1
i3yqm1vmn
9 Dec 20
Entry into a Material Definitive Agreement
4:38pm
424B5
n2yt2qwxqoilni8wv3qb
9 Dec 20
Prospectus supplement for primary offering
4:02pm
424B5
vx090w zn7mom9wq
7 Dec 20
Prospectus supplement for primary offering
4:10pm
8-K
EX-99.1
yues6
7 Dec 20
Regulation FD Disclosure
3:45pm
8-K
exfecns 4a
7 Dec 20
Regulation FD Disclosure
3:45pm
8-K
u2wvtvd14xsf 5rfx
4 Dec 20
Sutro Biopharma Announces Encouraging Interim Data on STRO-002 Phase 1 Dose-Escalation Study for Patients with Ovarian Cancer
12:00am
8-K
EX-99.1
8fekqo
4 Dec 20
Sutro Biopharma Announces Encouraging Interim Data on STRO-002 Phase 1 Dose-Escalation Study for Patients with Ovarian Cancer
12:00am
8-K
EX-99.1
7mzmxc90
5 Nov 20
Sutro Biopharma Reports Third Quarter 2020 Financial Results
7:05am
8-K
EX-99.1
f2wf8bi3
6 Aug 20
Sutro Biopharma Reports Second Quarter 2020 Financial Results
7:03am
8-K
ygb5xx90huh0b
12 May 20
Entry into a Material Definitive Agreement
5:14pm
8-K
EX-1.1
q6bhizzb 6y
12 May 20
Entry into a Material Definitive Agreement
5:14pm
424B5
2de90uv
12 May 20
Prospectus supplement for primary offering
5:02pm
8-K
EX-99.1
8df2b89 my2x
11 May 20
Sutro Biopharma Reports First Quarter 2020 Financial Results
4:27pm
424B5
wne3b7h3
11 May 20
Prospectus supplement for primary offering
4:12pm